RankAlpha logo
Back to Rankings

ZYBT

Zhengye BiotechnologyN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
ZYBT vs peer average
50/100
ZYBT vs. peer average (N/A vs. D)
Grade spread
A 1 · B 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

TXMD is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $23.61M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerTXMDTherapeuticsMD
ZYBT
Zhengye Biotechnology
TXMD
TherapeuticsMD
Grade
N/A
B
Momentum
79
86
Value
-
53
Sentiment
-
46
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs TXMD

ZYBT / TXMD
Grade Position
In line
ZYBT vs. peer average (N/A vs. D)
50/100
Momentum
79
TXMD
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ZYBT
1
TXMD
TherapeuticsMD Inc Common
B
80/100
-
2
BCTX
BriaCell Therapeutics Corp Common
F
20/100
-
3
MRKR
Marker Therapeutics Inc Common
B
80/100
-
4
VTGN
Vistagen Therapeutics Inc Common
F
20/100
-
5
LGVN
Longeveron Inc Class A Common
F
20/100
-
TXMD is the first peer returned for this comparison set.